SELE and cancer: Moreover, treating endothelial cells with E-selectin neutralizing antibody significantly reduced the effect of anti-miR-31 (Figure 4a and 4b, right panels), indicating that the increase in the adhesion of cancer cells mediated by inhibiting miR-31 was E-selectin-dependent.